SCHEDULE: Perceptive Advisors Amends Lyra Therapeutics Stake
Beneficial Ownership Report Amendment
Perceptive Advisors and affiliates updated their beneficial ownership in Lyra Therapeutics, Inc., now holding 15.55% of common stock.
Summary
- Perceptive Advisors LLC, Joseph Edelman, Perceptive Life Sciences Master Fund, Ltd., and Perceptive LS (A), LLC collectively reported beneficial ownership of 255,750 shares of Lyra Therapeutics, Inc. Common Stock.
- This aggregate ownership represents 15.55% of the outstanding common stock.
- The percentage is calculated based on 1,644,454 outstanding shares of Common Stock as of August 8, 2025, as reported by Lyra Therapeutics, Inc. in its Form 10-Q filed on August 12, 2025.
- Perceptive Life Sciences Master Fund, Ltd. holds 229,982 shares, representing 13.99% of the class.
- Perceptive LS (A), LLC holds 25,768 shares, representing 1.57% of the class.
Sentiment
Score: 5
Explanation: The filing is a routine amendment to beneficial ownership, providing factual data without indicating positive or negative operational or financial performance.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders are impacted by the disclosure of significant ownership concentration by Perceptive Advisors and its affiliates, which could influence future corporate actions or market perception.
Key Dates
| Date | Description |
|---|---|
| 08/08/2025 | Date as of which outstanding shares of Common Stock were reported by the Issuer in its Form 10-Q. |
| 08/12/2025 | Date of event which requires filing of this statement; also the filing date of the Issuer's Form 10-Q. |
| 08/14/2025 | Date of filing of this Schedule 13D Amendment No. 6. |
Keywords
Lyra Therapeutics, Perceptive Advisors, Joseph Edelman, Schedule 13D, Beneficial Ownership, Common Stock, Investment, Biotechnology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.